GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Total Payout Ratio

MicroTech Medical (Hangzhou) Co (HKSE:02235) Total Payout Ratio : 0.00 (As of Jun. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

MicroTech Medical (Hangzhou) Co's current Total Payout Ratio is 0.00.


MicroTech Medical (Hangzhou) Co Total Payout Ratio Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co Total Payout Ratio Chart

MicroTech Medical (Hangzhou) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Payout Ratio
- 0.07 34.42 - -

MicroTech Medical (Hangzhou) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Payout Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of MicroTech Medical (Hangzhou) Co's Total Payout Ratio

For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroTech Medical (Hangzhou) Co's Total Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where MicroTech Medical (Hangzhou) Co's Total Payout Ratio falls into.



MicroTech Medical (Hangzhou) Co Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

MicroTech Medical (Hangzhou) Co's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -136.74
=0.00

MicroTech Medical (Hangzhou) Co's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -116.327
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroTech Medical (Hangzhou) Co Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroTech Medical (Hangzhou) Co (HKSE:02235) Business Description

Traded in Other Exchanges
N/A
Address
No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.
Executives
Zheng Pan
Master Summer Limited 2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd 2201 Interest of corporation controlled by you
Cdbi Partners Fund Ii, L.p. 2201 Interest of corporation controlled by you
Cdbi Partners Fund I, L.p. 2201 Interest of corporation controlled by you
Cdbi Gp, Ltd 2201 Interest of corporation controlled by you
Cd Capital Healthcare Fund V, L.p. 2201 Interest of corporation controlled by you
Cd Capital Gp Ltd 2201 Interest of corporation controlled by you
Zhe Jiang Jiu Ren Zi Ben Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd. 2201 Interest of corporation controlled by you
Qiming Gp V, L.p. 2201 Interest of corporation controlled by you
Qiming Venture Partners V, L.p. 2201 Interest of corporation controlled by you
Qm32 Limited 2101 Beneficial owner
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Lav Evergreen (hong Kong) Co., Limited 2101 Beneficial owner

MicroTech Medical (Hangzhou) Co (HKSE:02235) Headlines

No Headlines